Chimeron Bio Corporation

Philadelphia, PA

UEI
GE9QEPP5XCA3
CAGE
7KN25
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
601 Walnut St, Philadelphia, PA 19106, USA
Website
chimeron.com
Founded
2015
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Chimeron Bio Corporation's latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Phase i therapeutic award: chimeric nanoparticle delivery of an sarna-based cancer vaccine for familial adenomatous… Contract · 75N91024C00011 National Cancer Institute $300,000

Quick answers

What is Chimeron Bio Corporation's UEI?

Chimeron Bio Corporation's Unique Entity ID (UEI) in SAM.gov is GE9QEPP5XCA3.

What is Chimeron Bio Corporation's CAGE code?

Chimeron Bio Corporation's CAGE code is 7KN25.

What is Chimeron Bio Corporation's primary NAICS code?

Chimeron Bio Corporation's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Chimeron Bio Corporation located?

Chimeron Bio Corporation's physical address in SAM.gov is 601 Walnut St, Philadelphia, PA 19106, USA.

Is Chimeron Bio Corporation registered in SAM.gov?

Yes. Chimeron Bio Corporation's SAM.gov registration is active through August 26, 2027.

What is Chimeron Bio Corporation's most recent federal award?

Chimeron Bio Corporation's most recent federal contract award is Phase i therapeutic award: chimeric nanoparticle delivery of an sarna-based cancer vaccine for familial adenomatous… (75N91024C00011), from National Cancer Institute, on February 21, 2024.

On GovTribe

See Chimeron Bio Corporation's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login